Cargando…

Time Above All Else: Pharmacodynamic Analysis of Β-Lactams in Critically Ill Patients

Background: Despite the development of new β-lactam agents, gram-negative resistance continues to be an increasing concern in the healthcare setting. The understanding and optimizing antimicrobial pharmacokinetics and pharmacodynamics are essential to enhance activity of appropriate therapy, improve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landmesser, Katherine, Burgess, David, Clark, Justin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Mdr Gnr
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551573/ http://dx.doi.org/10.1017/ash.2021.135

Ejemplares similares

Difference in Susceptibility Between Carbapenemase- and Non–Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae
por: Clark, Justin, et al.
Publicado: (2021)

Inpatient point-prevalence screening of New Delhi Metallo-β-lactamase (NDM)–producing Enterobacaterales and Candida auris
por: Greco, Christian, et al.
Publicado: (2022)

Evaluation of Ceftolozane/Tazobactam, Ceftazidime/Avibactam and Meropenem/Vaborbactam Against Multidrug-Resistant (MDR) Pseudomonas
por: Shamsulddin, Haider, et al.
Publicado: (2021)

Treatment of Extensively Drug-Resistant (XDR) Acinetobacter in US Veterans’ Affairs (VA) Medical Centers
por: Fitzpatrick, Margaret, et al.
Publicado: (2021)

How Does Antimicrobial Resistance Increase Medical Costs in Community-Acquired Acute Pyelonephritis?
por: Kim, Bongyoung, et al.
Publicado: (2021)

Stewardship Nightmare: Ceftolozane/Tazobactam–Resistant Pseudomonas aeruginosa Infections Accelerated by the COVID-19 Pandemic
por: Haviland, Adam, et al.
Publicado: (2021)

Management of Pseudomonas aeruginosa Bloodstream Infection and Impact on Health Outcomes
por: Ramanathan, Swetha, et al.
Publicado: (2021)

Pseudomonas aeruginosa bacteremia mortality and resistance trends in the Veterans’ Health Administration (VHA) system
por: Hojat, Leila, et al.
Publicado: (2022)

Low function and frequent readmission in nursing home patients with persistent resistant gram-negative bacterial colonization
por: Mills, John, et al.
Publicado: (2022)

A retrospective longitudinal observational study of natural history of ESBL/MDR gram negative organisms in patients hospitalized in a tertiary hospital
por: Vasudeva, Shikha, et al.
Publicado: (2022)

Characteristics of patients positive for COVID-19 and multidrug-resistant organisms in Tennessee, 2020–2021
por: Stover, Carolyn, et al.
Publicado: (2022)

Characterization of carbapenem-resistant gram-negative bacteria collected in the Sentinel Surveillance Program, 2018–2019
por: Spicer, Lori, et al.
Publicado: (2022)

Predicting the regional impact of interventions to prevent and contain multidrug-resistant organisms
por: Cincotta, Samuel, et al.
Publicado: (2022)

Carbapenemase genes and mortality in patients with carbapenem-resistant Enterobacterales, Atlanta, Georgia, 2011–2020
por: Witt, Lucy, et al.
Publicado: (2023)

Colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in hospitalized patients in Botswana
por: Mannathoko, Naledi Betsi, et al.
Publicado: (2023)

Whole-genome sequencing of carbapenem-resistant Enterobacterales isolates and evaluation of hospital-acquired infections
por: Ajaka, Leama, et al.
Publicado: (2023)

Real-world clinical outcomes of cefiderocol therapy in the Veterans Health Administration, 2019–2022
por: Amenta, Eva, et al.
Publicado: (2023)

Carbapenem-resistant Enterobacterales susceptibility patterns to new antimicrobials: A single-center analysis
por: Monk, Miranda, et al.
Publicado: (2023)

Identifying patients at high risk for carbapenem-resistant Enterobacterales carriage upon admission to acute-care hospitals
por: Howard-Anderson, Jessica, et al.
Publicado: (2023)

Pharmacokinetic/Pharmacodynamic Adequacy of Novel β-Lactam/β-Lactamase Inhibitors against Gram-Negative Bacterial in Critically Ill Patients
por: Han, Ruiying, et al.
Publicado: (2021)

Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients
por: Veiga, Rui Pedro, et al.
Publicado: (2018)

Pharmacodynamic optimization of β-lactams in the patient care setting
por: Nicolau, David P
Publicado: (2008)

SG-APSIC1097: The impact of COVID-19 on the incidence of carbapenem-resistant Enterobacterales (CRE) in Singapore: An interrupted time-series analysis
por: Ong, Chong Hui Clara, et al.
Publicado: (2023)

Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation
por: Bakdach, Dana, et al.
Publicado: (2022)

Broad-spectrum β-lactams in obese non-critically ill patients
por: Hites, M, et al.
Publicado: (2014)

Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams
por: Gonçalves-Pereira, Joao, et al.
Publicado: (2011)

Not all β-lactams are equal regarding neurotoxicity
por: Chaïbi, Khalil, et al.
Publicado: (2016)

SG-APSIC1159: Control of hospital-acquired carbapenemase-producing carbapenem-resistant Enterobacteriaceae colonization: A descriptive study
por: Wu, Tuodi, et al.
Publicado: (2023)

SG-APSIC1199: Evaluation of a pooling strategy using Xpert Carba-R assay for screening for carbapenemase-producing organisms in rectal swabs
por: Zhang, Peng, et al.
Publicado: (2023)

SG-APSIC1083: Prevalence and classification of carbapenemase-producing gram-negative bacilli at a medical center in Ho Chi Minh City, Vietnam
por: Huynh, Tuan, et al.
Publicado: (2023)

SG-APSIC1209: Risk factors associated with mortality among carbapenem-resistant Enterobacteriaceae inpatient in a tertiary-care teaching hospital in Malaysia
por: Sri Ponnampalavanar, Sasheela Sri La, et al.
Publicado: (2023)

SG-APSIC1073: Incidence and predictors of Escherichia coli–producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia, from 2010 to 2019: A population-based spatial analysis
por: Ling, Weiping, et al.
Publicado: (2023)

SG-APSIC1164: Cost-effectiveness of temporary isolation rooms in acute-care settings in Asia
por: Graves, Nicholas, et al.
Publicado: (2023)

SG-APSIC1069: Implementing infection prevention bundle significantly reduced multidrug-resistant organisms infection and healthcare-associated infections in intensive care unit at a national hospital in Vietnam
por: Phung, Thang, et al.
Publicado: (2023)

SG-APSIC1136: Multidrug-resistant organisms: Elevating issues identified by antimicrobial stewardship to improve infection control responses
por: Sheehan, Frances, et al.
Publicado: (2023)

SG-APSIC1081: Healthcare cost of antibiotic resistant infections: A hospital-based study in Vietnam
por: LanPham, Thi, et al.
Publicado: (2023)

SG-APSIC1096: Changes in resistance patterns of “ESKAPE” pathogens to azithromincin and levofloxacin in Yogyakarta
por: Asdie, Rizka, et al.
Publicado: (2023)

SG-APSIC1123: Diagnostic and infection prevention and control (IPC) performance of rapid polymerase chain reaction (PCR) compared to conventional culture PCR methods for detecting carbapenemase-producing organisms (CPOs)
por: Huan, Xiaowei, et al.
Publicado: (2023)

SG-APSIC1157: The attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections—A prospective cohort study in Suva, Fiji
por: Loftus, Michael, et al.
Publicado: (2023)

SG-APSIC1095: Acquisition rate of carbapenemase-producing organisms (CPOs) among hospital contacts of CPO patients: An interim subgroup analysis of a cohort study
por: Husen, Sharifah Farhanah Syed, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eijeua902kao4rtng8461ogf6g